Clinical Gastroenterology & Hepatology AGA

A study in the March 2015 issue of CGH finds that withdrawal of immunomodulators after at least 6 months of co-treatment with infliximab does not reduce the trough levels of infliximab in patients with Crohn's disease.

An article in the February issue of CGH looks at solutions to issues concerning fecal microbiota transplantation, and challenges involving this increasingly common procedure that still remain. Dr. Kuemmerle speaks with author Dr. Alexander Khoruts.

An article in the January issue of CGH investigated the incidence, etiology, and outcome of GI bleeding in patients with ventricular assist devices. Dr. Kuemmerle speaks to co-author Dr. John Vargo of the Cleveland Clinic.

A study in the November issue of CGH investigated whether increasing doses of mesalamine reduces concentrations of fecal calprotectin in patients with quiescent ulcerative colitis. Dr. Kuemmerle speaks to author Dr. James D. Lewis.

An AGA Board Strategic Update article in the October issue of CGH discusses recent changes to how a gastroenterologist demonstrates value in the era of the Affordable Care Act. Dr. Kuemmerle speaks to Dr. Lawrence Kosinski.

An article and accompanying editorial in the September issue of CGH discuss reinitiating infliximab therapy for inflammatory bowel disease patients after a period of discontinuation. Dr. Kuemmerle speaks w/ editorial co-author Dr. Maria T. Abreu.